Methodological rigour and transparency are required for genotyping methods in genetic association studieson March 3, 2026 at 12:15 pm
Publication date: 15 April 2026 Source: Clinica Chimica Acta, Volume 586 Author(s): Aditya K. Panda
Journal
Differences in laboratory reporting of thyroglobulin antibody positivity – a national survey across laboratories in the NetherlandsEliane F E Wenstedton March 2, 2026 at 11:00 am
Clin Chem Lab Med. 2026 Mar 3. doi: 10.1515/cclm-2026-0056. Online ahead of print. NO ABSTRACT PMID:41771274 | DOI:10.1515/cclm-2026-0056
Diagnostic performance evaluation of the Siemens Healthineers Atellica HEMA 580 hematology analyzer for abnormal cell detection and optimization of immature myeloid cell cut-offsVincenzo De Iuliison March 2, 2026 at 11:00 am
Clin Chem Lab Med. 2026 Mar 3. doi: 10.1515/cclm-2026-0083. Online ahead of print. ABSTRACT OBJECTIVES: We evaluated the diagnostic performance of the Atellica HEMA 580 hematology analyzer for complete blood count (CBC) parameters compared with the ADVIA 2120i and assessed its capability to flag abnormal cells, and determined optimal cut-offs for immature myeloid cell detection. … Read more
The conventional reference interval model: a historical framework?Werner Wosniokon March 2, 2026 at 11:00 am
Clin Chem Lab Med. 2026 Mar 2. doi: 10.1515/cclm-2026-0169. Online ahead of print. NO ABSTRACT PMID:41766327 | DOI:10.1515/cclm-2026-0169
Urinary aldosterone and tetrahydroaldosterone by LC-MS/MS with enzymatic hydrolysis: validation and age-stratified reference intervalsIrene Wijbenga-van der Kooion March 1, 2026 at 11:00 am
Clin Chem Lab Med. 2026 Mar 2. doi: 10.1515/cclm-2025-1679. Online ahead of print. ABSTRACT OBJECTIVES: Primary aldosteronism (PA) is a common cause of secondary hypertension. To address the specificity limits of immunoassays, we developed and validated an LC-MS/MS method for urinary aldosterone and tetrahydroaldosterone and established method-matched reference intervals for excretion in 24 h urine. … Read more
Machine learning-based integration of antiphospholipid antibodies for predicting pregnancy outcomes in patients with recurrent spontaneous abortion: a multicenter prospective studyXinli Jiangon March 1, 2026 at 11:00 am
Clin Chem Lab Med. 2026 Mar 2. doi: 10.1515/cclm-2026-0088. Online ahead of print. ABSTRACT OBJECTIVES: Antiphospholipid antibodies (aPLs) are closely associated with recurrent spontaneous abortion (RSA) and adverse pregnancy outcomes (POs). Non-criteria aPLs may aid in diagnosing seronegative aPL-related RSA, but their limited performance often leads to missed or delayed diagnosis. This study aimed to … Read more
Optimising lipoprotein(a) tests: we are almost thereMichel R Langloison March 1, 2026 at 11:00 am
Clin Chem Lab Med. 2026 Mar 2. doi: 10.1515/cclm-2026-0269. Online ahead of print. NO ABSTRACT PMID:41764779 | DOI:10.1515/cclm-2026-0269
Explainable machine learning framework based on blood biomarkers and routine health information for assistive diagnosis and risk stratification of acute myocardial infarctionon February 28, 2026 at 2:53 pm
Publication date: 15 April 2026 Source: Clinica Chimica Acta, Volume 586 Author(s): Xinglong Zhu, Ting Wang, Jidong Jiang, Minghui Zhang, Tao Liu, Xiaodong Zhang, Yiqing Wang
Multi-omics biomarkers in cadmium-related lung toxicity and carcinogenesison February 28, 2026 at 2:53 pm
Publication date: 15 April 2026 Source: Clinica Chimica Acta, Volume 586 Author(s): Khalid Saad Alharbi
EGFR as a biomarker in colorectal Cancer: An electrochemical biosensing approachon February 28, 2026 at 2:53 pm
Publication date: 15 April 2026 Source: Clinica Chimica Acta, Volume 586 Author(s): Mohammed Khaled Bin Break, Rahamat Unissa Syed, Weiam Hussein, Muhammad Nawaz, Randa Abdeen Hussein Abdalla, Nayla Ahmed Mohammed Aboshouk, Teng-Jin Khoo, Hemat A. Elariny, Afrah E. Mohammed, Sahar S. Alghamdi